{"id":"mozavaptan","rwe":[],"tags":[{"label":"mozavaptan","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Vasopressin V2 receptor","category":"target"},{"label":"AVPR2","category":"gene"},{"label":"AVPR1A","category":"gene"},{"label":"OXTR","category":"gene"},{"label":"Active","category":"status"},{"label":"Paraneoplastic hyponatremia","category":"indication"},{"label":"Otsuka Pharmaceutical Co., Ltd.","category":"company"},{"label":"Antidiuretic Hormone Receptor Antagonists","category":"pharmacology"},{"label":"Natriuretic Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Otsuka Pharmaceutical Co., Ltd.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=MOZAVAPTAN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:22:24.647081+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:22:32.165991+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MOZAVAPTAN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:22:32.992834+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5087555/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:33.493182+00:00"}},"allNames":"physulime","offLabel":[],"synonyms":["mozavaptan","mozavaptan hydrochloride","physulime","OPC-31260","mozavaptan HCl"],"timeline":[{"date":"2006-07-26","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Otsuka Pharmaceutical Co., Ltd.)"}],"approvals":[{"date":"2006-07-26","orphan":false,"company":"Otsuka Pharmaceutical Co., Ltd.","regulator":"PMDA"}],"brandName":"Physulime","ecosystem":[{"indication":"Paraneoplastic hyponatremia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"Vasopressin V2 receptor","targets":[{"gene":"AVPR2","source":"DrugCentral","target":"Vasopressin V2 receptor","protein":"Vasopressin V2 receptor"},{"gene":"AVPR1A","source":"DrugCentral","target":"Vasopressin V1a receptor","protein":"Vasopressin V1a receptor"},{"gene":"OXTR","source":"DrugCentral","target":"Oxytocin receptor","protein":"Oxytocin receptor"},{"gene":"AVPR1B","source":"DrugCentral","target":"Vasopressin V1b receptor","protein":"Vasopressin V1b receptor"}],"modality":"Small Molecule","drugClass":"mozavaptan","explanation":"","oneSentence":"","technicalDetail":"Mozavaptan acts as a selective antagonist of the vasopressin V2 receptor, inhibiting the renal reabsorption of water and increasing the excretion of free water, thereby correcting hyponatremia."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4004","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MOZAVAPTAN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:51:37.827054","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:35.354879+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"conivaptan","drugSlug":"conivaptan","fdaApproval":"2005-12-29","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"desmopressin","drugSlug":"desmopressin","fdaApproval":"1978-02-21","patentExpiry":"May 21, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"diethylstilbestrol","drugSlug":"diethylstilbestrol","fdaApproval":"1973-05-30","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"oxytocin","drugSlug":"oxytocin","fdaApproval":"1980-04-17","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"ritonavir","drugSlug":"ritonavir","fdaApproval":"1996-03-01","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"saquinavir","drugSlug":"saquinavir","fdaApproval":"1995-12-06","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"terlipressin","drugSlug":"terlipressin","fdaApproval":"2022-09-14","patentExpiry":"Apr 5, 2037","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"tolvaptan","drugSlug":"tolvaptan","fdaApproval":"2009-05-19","patentExpiry":"Sep 1, 2026","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"vasopressin","drugSlug":"vasopressin","fdaApproval":"","patentExpiry":"Sep 27, 2044","patentStatus":"Patent protected","relationship":"same-target"}],"genericName":"mozavaptan","indications":{"approved":[{"name":"Paraneoplastic hyponatremia","source":"DrugCentral","snomedId":405566004,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"conivaptan","brandName":"conivaptan","genericName":"conivaptan","approvalYear":"2005","relationship":"same-target"},{"drugId":"desmopressin","brandName":"desmopressin","genericName":"desmopressin","approvalYear":"1978","relationship":"same-target"},{"drugId":"diethylstilbestrol","brandName":"diethylstilbestrol","genericName":"diethylstilbestrol","approvalYear":"1973","relationship":"same-target"},{"drugId":"oxytocin","brandName":"oxytocin","genericName":"oxytocin","approvalYear":"1980","relationship":"same-target"},{"drugId":"ritonavir","brandName":"ritonavir","genericName":"ritonavir","approvalYear":"1996","relationship":"same-target"},{"drugId":"saquinavir","brandName":"saquinavir","genericName":"saquinavir","approvalYear":"1995","relationship":"same-target"},{"drugId":"terlipressin","brandName":"terlipressin","genericName":"terlipressin","approvalYear":"2022","relationship":"same-target"},{"drugId":"tolvaptan","brandName":"tolvaptan","genericName":"tolvaptan","approvalYear":"2009","relationship":"same-target"},{"drugId":"vasopressin","brandName":"vasopressin","genericName":"vasopressin","approvalYear":"","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"17OJ42922Y","CHEBI":"CHEBI:135694","INN_ID":"8248","UMLSCUI":"C2975283","chemblId":"CHEMBL5087555","ChEMBL_ID":"CHEMBL420762","KEGG_DRUG":"D01855","PUBCHEM_CID":"119369","IUPHAR_LIGAND_ID":"2197","SECONDARY_CAS_RN":"138470-70-9","MESH_SUPPLEMENTAL_RECORD_UI":"C076251"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Otsuka Pharmaceutical Co., Ltd.","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"1%"},"publicationCount":21,"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Otsuka Pharmaceutical Co., Ltd.","companyId":"otsuka-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"2006","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2006-07-26T00:00:00.000Z","mah":"Otsuka Pharmaceutical Co., Ltd.","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:35.354879+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}